AU2932699A - Oral pharmaceutical compositions to be taken without liquids, which contain inclusion complexes - Google Patents

Oral pharmaceutical compositions to be taken without liquids, which contain inclusion complexes

Info

Publication number
AU2932699A
AU2932699A AU29326/99A AU2932699A AU2932699A AU 2932699 A AU2932699 A AU 2932699A AU 29326/99 A AU29326/99 A AU 29326/99A AU 2932699 A AU2932699 A AU 2932699A AU 2932699 A AU2932699 A AU 2932699A
Authority
AU
Australia
Prior art keywords
liquids
taken
pharmaceutical compositions
oral pharmaceutical
inclusion complexes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29326/99A
Inventor
Roberto Golzi
Caterina Lazzarini
Luciano Marcelloni
Giancarlo Santus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Recordati SA
Original Assignee
Recordati SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati SA filed Critical Recordati SA
Publication of AU2932699A publication Critical patent/AU2932699A/en
Abandoned legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU29326/99A 1998-03-13 1999-03-10 Oral pharmaceutical compositions to be taken without liquids, which contain inclusion complexes Abandoned AU2932699A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI98A0511 1998-03-13
IT98MI000511A IT1298732B1 (en) 1998-03-13 1998-03-13 ORAL PHARMACEUTICAL COMPOSITIONS ASSUMABLE WITHOUT LIQUIDS, CONTAINING INCLUSION COMPLEXES
PCT/EP1999/001540 WO1999047172A2 (en) 1998-03-13 1999-03-10 Oral pharmaceutical compositions to be taken without liquids, which contain inclusion complexes

Publications (1)

Publication Number Publication Date
AU2932699A true AU2932699A (en) 1999-10-11

Family

ID=11379303

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29326/99A Abandoned AU2932699A (en) 1998-03-13 1999-03-10 Oral pharmaceutical compositions to be taken without liquids, which contain inclusion complexes

Country Status (3)

Country Link
AU (1) AU2932699A (en)
IT (1) IT1298732B1 (en)
WO (1) WO1999047172A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN190018B (en) * 1999-09-28 2003-05-31 Panacea Biotec Ltd
ES2265439T3 (en) * 2000-08-18 2007-02-16 Pharmacia Corporation ORAL FORMULATION OF VALDECOXIB THAT DISAPPEARS RAPIDLY.
TWI321054B (en) 2000-12-19 2010-03-01 California Inst Of Techn Compositions containing inclusion complexes
EP1258241A1 (en) * 2001-05-16 2002-11-20 BIOPROGRESS S.p.A. Method of increasing the bioavailability of nimesulide
EP1534340B1 (en) 2002-09-06 2011-11-16 Cerulean Pharma Inc. Cyclodextrin-based polymers for delivering the therapeutic agents covalently bound thereto
CN1717209A (en) 2002-10-09 2006-01-04 植入疗法公司 Cyclodextrin-based materials, compositions and uses related thereto
AR053023A1 (en) * 2005-02-25 2007-04-18 Recordati Ireland Ltd LERCANIDIPINE FREE BASE, METHODS FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US20080176958A1 (en) 2007-01-24 2008-07-24 Insert Therapeutics, Inc. Cyclodextrin-based polymers for therapeutics delivery
US20140094432A1 (en) 2012-10-02 2014-04-03 Cerulean Pharma Inc. Methods and systems for polymer precipitation and generation of particles

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2660195B1 (en) * 1990-03-28 1994-10-07 Crinex Sa Laboratoires PHARMACEUTICAL CHEWING, ANTI-INFLAMMATORY AND / OR ANALGESIC COMPOSITION.
IT1248475B (en) * 1990-05-22 1995-01-19 Angeli Inst Spa INCLUSION COMPOUNDS OF NIMESULIDE WITH CYCLODESTRINE
DE4038314A1 (en) * 1990-11-30 1992-06-04 Puetter Medice Chem Pharm COMPLEXES OF THE ACTIVE ENANTIOMER OF THE IBUPROFEN WITH CYCLODEXTRIN
IT1255462B (en) * 1992-07-28 1995-11-02 Grazia Maffione METHOD OF PREPARATION OF NIMESULIDE INCLUSION COMPOUNDS WITH CYCLODESTRINE
IT1274241B (en) * 1993-12-03 1997-07-15 Smithkline Beecham Farma THERAPEUTIC AGENT / POLYMER MATRIX COMPLEXES EQUIPPED WITH IMPROVED FLAVOR CHARACTERISTICS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US5866179A (en) * 1996-05-03 1999-02-02 Avant-Garde Technologies & Products S.A. Medicated chewing gum and a process for preparation thereof
CN1176784A (en) * 1997-07-24 1998-03-25 北京路德有限责任公司 Method for preparing masticatory tablet of acetaminophen, and the product thereof

Also Published As

Publication number Publication date
WO1999047172A2 (en) 1999-09-23
WO1999047172A3 (en) 1999-11-11
IT1298732B1 (en) 2000-02-02
ITMI980511A1 (en) 1999-09-13

Similar Documents

Publication Publication Date Title
ZA200200741B (en) Oral liquid compositions.
AU781269C (en) Pharmaceutical compositions
HUP0102483A3 (en) Pharmaceutical compositions containing androst-5-ene-3betha,17betha-diol
AU2002229065A1 (en) Compositions containing inclusion complexes
HK1045650A1 (en) Pharmaceutical composition.
IL138280A0 (en) 20-KETO-11β-ARYLSTERIODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF
AU3192700A (en) Medicinal compositions
AU2001250420A1 (en) Pharmaceutical compositions
AU2001274307A1 (en) Pharmaceutical compositions
IL145290A0 (en) Pharmaceutical compositions comprising complexes
HK1038884A1 (en) Medicinal compositions.
AU2002217464A1 (en) Medicinal compositions containing aspirin
AU1574900A (en) Pharmaceutical compositions containing insulin
ZA200203486B (en) Novel pharmaceutical compositions.
AU4143999A (en) Oral composition comprising capsules
AU2005300A (en) Medicinal compositions
AU1887401A (en) Medicinal composition
AU761544C (en) Medicinal compositions containing anti-Fas antibody
ZA200005510B (en) Pharmaceutical composition.
AU1735001A (en) Cyclodextrin-containing pharmaceutical composition
ZA200000857B (en) Pharmaceutical composition.
AU4428000A (en) Pulse-delivery oral compositions
ZA200203077B (en) Ciclesonide contained pharmaceutical composition for application to mucosa.
AU6460400A (en) Pharmaceutical compositions
AU2932699A (en) Oral pharmaceutical compositions to be taken without liquids, which contain inclusion complexes

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase